Home › Funds › Van Berkom & Associates Inc. › CHE

Van Berkom & Associates Inc. position in CHE

CHEMED CORP NEW · Health Care

Van Berkom & Associates Inc. reported holding 120,960 shares of CHE (CHEMED CORP NEW) in its Q3 2026 13F filing — a position valued at US$61.1M, representing 2.18% of its reported portfolio and ranking #26 among its reported holdings. Van Berkom & Associates Inc. has disclosed CHE holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)120.96K sh
Reported value held$61.09M
Portfolio Weight2.18%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Van Berkom & Associates Inc.'s CHE position evolved

Van Berkom & Associates Inc. first disclosed a stake in CHE in Q3 2023 at 130,012 shares (US$67.6M). The position peaked in Q3 2024 at 135,683 shares, worth US$81.5M. Across 13 filings, Van Berkom & Associates Inc. increased the stake 5 time(s), trimmed it 7 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 120,960 shares valued at US$61.1M — a reduction of -41,849 shares quarter over quarter.. Notable position changes include a 33% increase in Q3 2025 (shares fell 4% over the following quarter), a 26% trim in Q3 2026 (shares rose 9% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 130.01K $67.57M New
Q4 2023 118.55K $69.32M Reduce
Q1 2024 115.82K $74.35M Reduce
Q2 2024 129.96K $70.51M Add
Q3 2024 135.68K $81.54M Add
Q4 2024 128.47K $68.06M Reduce
Q1 2025 107.99K $66.45M Reduce
Q2 2025 128.42K $62.53M Add
Q3 2025 170.81K $76.48M Add
Q4 2025 174.87K $74.82M Add
Q1 2026 165.09K $62.36M Reduce
Q2 2026 162.81K $75.83M Reduce
Q3 2026 120.96K $61.09M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CHE and 13F data

CHE (CHEMED CORP NEW) is a Health Care company. 23 other funds we track also report a position in CHE — the largest reported positions include Epoch Investment Partners, Inc. (US$124.8M), River Road Asset Management, LLC (US$100.5M), Boston Trust Walden Corp (US$96.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CHE

All CHE fund holders →

FAQ

How long has Van Berkom & Associates Inc. held CHE?

Van Berkom & Associates Inc. has disclosed CHE holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Van Berkom & Associates Inc.'s current position in CHE?

As of Q3 2026, Van Berkom & Associates Inc. holds 120.96K shares of CHE (CHEMED CORP NEW), valued at $61.09M, representing 2.18% of its reported portfolio and ranking #26.

Has Van Berkom & Associates Inc. been buying or selling CHE?

In the latest 13F filing (Q3 2026), Van Berkom & Associates Inc. reduced its position in CHE. The position peaked in Q3 2024 at 135.68K shares.

Which other funds hold CHE?

Other major institutional holders of CHE include Epoch Investment Partners, Inc., River Road Asset Management, LLC, Boston Trust Walden Corp, among 23 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.